Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
jose antonio estrada
(5 results)?
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.
Vaccine. 2023 Jan 4;41(1):109-118. doi: 10.1016/j.vaccine.2022.10.030. Epub 2022 Nov 18.
Vaccine. 2023.
PMID: 36404171
Free PMC article.
Clinical Trial.
An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901.
Estrada JA, Cheng CY, Ku SY, Hu HC, Yeh HW, Lin YC, Chen CP, Cheng SH, Janssen R, Lin IF.
Estrada JA, et al.
Vaccines (Basel). 2022 Apr 21;10(5):655. doi: 10.3390/vaccines10050655.
Vaccines (Basel). 2022.
PMID: 35632411
Free PMC article.
Item in Clipboard
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Estephan L, Lin YC, Lin YT, Chen YH, Pan SC, Hsieh SM, Torkehagen PF, Weng YJ, Cheng HY, Estrada JA, Waits A, Chen C, Lien CE.
Estephan L, et al. Among authors: estrada ja.
Vaccine. 2023 May 26;41(23):3497-3505. doi: 10.1016/j.vaccine.2023.04.029. Epub 2023 Apr 12.
Vaccine. 2023.
PMID: 37080829
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite